Main logo
tutorial arrow
Create your own tool library
Bookmark tools and put favorites into folders to find them easily.



Stores and manages proteomics data. 2D-PAGE may be used to publish two-dimensional electrophoretic proteomics data, and also may be accessed by external users who want to compare their own data with those in the databases. Users can introduce mass spectra into the database, which allows the searching of peptide mass fingerprints against their own protein sequence databases. Currently, the 2D-PAGE proteome database at MPI for Infection Biology is serving as one of the working standards, together with the SWISS-2DPAGE standard, within the European network project on human pathogenic bacteria.

User report

tutorial arrow
Vote up tools and offer feedback
Give value to tools and make your expertise visible
Give your feedback on this tool
Sign up for free to join and share with the community

0 user reviews

0 user reviews

No review has been posted.

2D-PAGE forum

tutorial arrow
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.
Take part in the discussion
Sign up for free to ask question and share your advices

No open topic.

2D-PAGE classification

2D-PAGE specifications

Restrictions to use:
Community driven:
User data submission:
Not allowed
Database management system:
Data access:

2D-PAGE support


  • Peter Jungblut <>


tutorial arrow
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.
Promote your work
Sign up for free to badge your contributorship



Max Planck Institute for Infection Biology, Core Facility Bioinformatics, Berlin, Germany; Algorithmus, Berlin, Germany; Max Planck Institute for Infection Biology, Core Facility Protein Analysis, Berlin, Germany

Funding source(s)

This work was supported by European Union (EBP: QLRT-1999- 31536) and the combination with PEDANT by BMBF (O31U107A and O31U207A).

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.